SAM #75N98026Q00822

NIH Procurement for Thyroseq V3 Molecular Testing of Thyroid Nodule Biopsies

This opportunity is for advanced molecular testing services to support thyroid nodule diagnosis at the National Institutes of Health (NIH). - Government Buyer: - National Institutes of Health (NIH), Office of the Director, Office of Acquisitions - OEMs and Vendors: - Thyroseq (primary referenced product; OEM: Sonic Healthcare USA, Inc. / ThyroSeq Laboratory at University of Pittsburgh Medical Center) - Products/Services Requested: - Thyroseq V3 molecular testing for fine needle aspiration biopsy samples of thyroid nodules - Up to 20 nodules per year - Next-generation sequencing of approximately 110 thyroid cancer-related genes - Includes sample collection and storage equipment - Detailed mutation and malignancy risk reports with recommended management steps - Results required within 2 weeks of sample receipt - Unique/Notable Requirements: - Contractor must provide all necessary collection/storage equipment - Reports must be comprehensive and include management recommendations - Strict 2-week turnaround for test results - Firm-fixed-price contract structure - Not set aside for small businesses; open competition - Evaluation factors include technical capability, price, past performance, and delivery schedule

Description

See attached combines Synopsis.

View original listing